• Hypoxia and Immunometabolism: Mechanisms in Tumor Progressio

  2026-07-22

  The reference review dissects how tumor hypoxia and altered immunometabolism drive the formation of an immunosuppressive tumor microenvironment (TME), facilitating malignant progression. It synthesizes mechanistic insights into metabolic reprogramming and immune cell adaptation, outlining prospects and challenges for targeting these processes in cancer therapy.

• Brassinolide (A3265): Integrative Mechanisms in Plant and Bi

  2026-07-21

  Explore how Brassinolide, a leading plant sterol, uniquely shapes plant development and biomedical research by modulating root growth and inducing apoptosis. This article offers advanced mechanistic insights, practical assay guidance, and a critical synthesis of new findings beyond standard protocols.

• Cisplatin (SKU A8321): Practical Solutions for Cancer Resear

  2026-07-21

  This article delivers evidence-based guidance for leveraging Cisplatin (SKU A8321) in cancer research workflows, addressing real-world laboratory challenges in apoptosis assays, xenograft models, and chemotherapy resistance studies. Integrating recent mechanistic insights and practical tips, it demonstrates how Cisplatin from APExBIO provides reproducible, data-backed solutions for bench scientists.

• Z-DEVD-FMK: Caspase-3 Inhibitor in Antiviral and Neuroprotec

  2026-07-20

  Explore the advanced use of Z-DEVD-FMK as a caspase-3 inhibitor in both apoptosis assays and antiviral research, with a focus on its translational impact in neuroprotection and emerging viral pathogenesis models. Gain new insights into assay design, mechanism, and cross-domain applications.

• IGF2BP1-m6A-TUBB4B Axis Drives Hepatic Stellate Cell Activat

  2026-07-20

  This study identifies the m6A reader IGF2BP1 as a pivotal driver of hepatic stellate cell (HSC) activation and liver fibrosis by stabilizing TUBB4B mRNA through m6A-dependent mechanisms. The elucidation of the IGF2BP1/TUBB4B/FAK signaling axis highlights a promising antifibrotic target and offers novel insight for translational research in liver disease.

• Gemcitabine in Cancer Research: Applied Workflows and Protoc

  2026-07-19

  Gemcitabine, a potent DNA synthesis inhibitor, is transforming apoptosis and DNA damage response assays in cancer research. This article delivers actionable protocol enhancements, troubleshooting strategies, and practical insights for leveraging Gemcitabine in translational oncology, with evidence-driven comparisons to emerging therapeutics.

• Neuroligin 1 Loss Drives Repetitive Behavior via Striatal D2

  2026-07-18

  This study demonstrates that Neuroligin 1 deficiency in striatal D2 receptor-expressing medium spiny neurons leads to hyperactivation and increased repetitive behaviors, key features of autism spectrum disorder. The findings clarify cellular mechanisms underlying restricted and repetitive behaviors, highlighting PKC overactivation and suggesting novel circuit-level intervention strategies.

• Hydroxychloroquine Sulfate: Technical Guide for Autoimmune R

  2026-07-17

  Hydroxychloroquine Sulfate (SKU B4874) provides researchers with a reliable, water-soluble inhibitor of autophagy and TLR7/9 signaling for autoimmune disease models. It is best suited to aqueous protocols in systemic lupus erythematosus and rheumatoid arthritis research, but should not be used for workflows requiring organic solvent solubility or long-term solution storage.

• Tropifexor (LJN452): Advancing FXR Modulation in Translation

  2026-07-17

  Explore how Tropifexor (LJN452) redefines FXR-targeted approaches in metabolic and intestinal barrier research. This article synthesizes mechanistic insights, translational evidence, and practical protocol guidance, establishing new benchmarks for researchers navigating the metabolic-liver-intestinal axis.

• Self-Assembly Behavior of ABC Coil-Bottlebrush Block Terpoly

  2026-07-16

  The reference study systematically examines the self-assembly of shaped ABC coil-bottlebrush block terpolymers, revealing how bottlebrush architecture suppresses the formation of gyroid network phases and alters phase transitions compared to classical diblock copolymers. These findings inform the rational design of nanostructured polymer materials where domain size, morphology, and ordering kinetics are critical parameters.

• BIIE 0246: Potent Neuropeptide Y Y2 Receptor Antagonist Prof

  2026-07-16

  BIIE 0246 is a highly selective neuropeptide Y Y2 receptor antagonist with nanomolar affinity, enabling precise inhibition of presynaptic Y2R functions in neuroscience and metabolic studies. Its specificity and potency support rigorous dissection of NPY-mediated pathways in both central and peripheral systems.

• Modeling HSV-1 Latency in Human iPSC-Derived Sensory Neurons

  2026-07-15

  This study establishes a robust protocol for differentiating human inducible pluripotent stem cells into sensory neurons that can support latent HSV-1 infection and reactivation. The model overcomes key limitations of animal systems, offering a scalable, human-relevant platform to investigate mechanisms underlying HSV-1 persistence and reactivation, with broad implications for neurovirology and therapeutic discovery.

• Genistein: Selective Tyrosine Kinase Inhibitor and Cancer Re

  2026-07-15

  Genistein (5,7-dihydroxy-3-(4-hydroxyphenyl)chromen-4-one) is a potent, selective inhibitor of protein tyrosine kinases used in cancer chemoprevention and cell signaling research. Its effectiveness in suppressing EGF- and insulin-mediated proliferation is well-documented, and it serves as a benchmark tool in apoptosis assays and mechanotransduction studies.

• Toremifene vs Tamoxifen in Advanced Breast Cancer: Cochrane

  2026-07-14

  This Cochrane meta-analysis rigorously compares the efficacy and safety profiles of toremifene and tamoxifen as oral selective estrogen receptor modulators for advanced breast cancer. The findings show comparable clinical outcomes and inform evidence-based choices in breast cancer and endocrinology research.

• Reliable Pyroptosis Detection with Caspase-4 Colorimetric As

  2026-07-14

  This article provides scenario-driven, evidence-based guidance for scientists using the Caspase-4 Colorimetric Assay Kit (SKU K2199). It details practical solutions to common workflows in pyroptosis, apoptosis, and inflammasome research, emphasizing protocol optimization, data interpretation, and product selection, with curated scientific references and real-world laboratory scenarios.

442 records 10/30 page Previous Next First page 上5页 678910 下5页 Last page